Type 5 Cardiorenal Syndrome: An Underdiagnosed and Underrecognized Disease Process of the American Mother
- PMID: 36406945
- PMCID: PMC9635802
- DOI: 10.14740/jocmr4792
Type 5 Cardiorenal Syndrome: An Underdiagnosed and Underrecognized Disease Process of the American Mother
Abstract
Cardiorenal syndrome (CRS) continues to be an area of concern due to the changing understanding of identification, pathophysiology and optimal management. Originally thought that diuretics were always the answer, recent literature has shed lights on the five major CRS subphenotypes, and while conceptual in their classifications, different strategies may be utilized to manage each type. The effect of CRS in pregnant women is largely under discussed and underappreciated as its own entity. Trials involving possible management, specifically utilizing serelaxin, a recombinant form of relaxin, have shown promising results but more data are needed to begin implementing it on a large scale.
Keywords: Cardiorenal syndrome; Pregnant women; Serelaxin; Type 5.
Copyright 2022, Ilagan et al.
Conflict of interest statement
None to declare.
References
-
- Report from nine maternal mortality review committees. n.d.). https://www.cdcfoundation.org/sites/default/files/files/ReportfromNineMM....
-
- Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV. et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840–e878. doi: 10.1161/CIR.0000000000000664. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources